In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24?weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24?weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline

作者姓名：	Kawashiri SY Kawakami A Iwamoto N Fujikawa K Aramaki T Tamai M Yamasaki S Nakamura H Origuchi T Ueki Y Migita K Mizokami A Aoyagi K Eguchi K

摘要：
本文献已被 PubMed SpringerLink 等数据库收录！